In Memoriam: Dry-eye researcher dies

Article

Jeffrey P. Gilbard, MD, founder, chief executive officer, and chief scientific officer of Advanced Vision Research, died Aug. 12, following complications from a bicycling accident.

That drive to help people and solve a problem few were willing or able to tackle motivated Dr. Gilbard to develop a line of products that helped relieve their suffering and treat dry eye disease.

Dr. Gilbard, the founder, chief executive officer, and chief scientific officer of Advanced Vision Research, died Aug. 12 following complications from a bicycling accident.

While riding his bicycle with his wife on July 19, Dr. Gilbard struck an object in the road and fell. He died 3 weeks later at Massachusetts General Hospital in Boston. In addition to his wife, he is survived by two sons and a daughter.

Dr. Gilbard was a frequent visitor to optometry meetings, where he was eager to share his knowledge of dry eye. His company also became the first corporate sponsor of the Ocular Surface Society of Optometry (OSSO).

"What was critical was his identification that tear film osmolarity was an important indicator of an inadequate or unhealthy tear film," said Katherine Mastrota, OD, an optometrist in private practice in New York, NY, and OSSO secretary. "Then he was able to modify [the tear film] by adding micronutrients and bicarbonate and potassium rather than having a solution that was just electrolytes, polymer to increase viscosity and a preservative. He was able to make something that more effectively mirrored a natural tear."

In 1976, as a young medical student, Dr. Gilbard was astounded by how little was available to help patients with dry eye disease. In 1978, he received funding from the National Eye Institute to research the causes and treatment of dry eye, and his lifetime of work spawned a greater understanding of ocular surface disease, Dr. Mastrota said.

Dr. Gilbard's pioneering work led to a better understanding of tear film osmolarity and a realization that a loss of water in the tears makes them hyper-osmotic. His hypo-osmotic TheraTears Lubricant Eye Drops, launched in 1995, were developed to lower the high-salt concentration, balance the electrolytes in the eye, and offer a lubricant to relieve irritation.

He developed related products, including a vitamin supplement with Omega-3 oils to support healthy tear production, and an eyelid cleanser to remove bacteria that can lead to blepharitis and exacerbate dry eye.

"As people get older, they get dry eyes or they have meibomian gland dysfunction, and they become contact lens-intolerant," said Larry Bickford, OD, in private practice in Santa Barbara, CA, and a longtime friend of Dr. Gilbard. "Instead of throwing drops at them, we now know what we can do to remediate their problem. It's pretty awesome to consider that, thanks to him, we have a pretty good handle on what makes people have this problem."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.